Related references
Note: Only part of the references are listed.Cancer Therapy Due to Apoptosis: Galectin-9
Koji Fujita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
Donnele Daley et al.
NATURE MEDICINE (2017)
Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
Monica Gordon-Alonso et al.
NATURE COMMUNICATIONS (2017)
The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment
Tseng-Cheng Chen et al.
SCIENTIFIC REPORTS (2017)
Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells
Tushar Piyush et al.
CELL DEATH AND DIFFERENTIATION (2017)
Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis
Santiago P. Mendez-Huergo et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Galectin-9 suppresses the proliferation of gastric cancer cells in vitro
Jitsuko Takano et al.
ONCOLOGY REPORTS (2016)
Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms
Jacquelyn M. Lykken et al.
BLOOD (2016)
Galectin-9: An anticancer molecule for gallbladder carcinoma
Tomoko Tadokoro et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
IMMUNOTHERAPY PD-1 says goodbye, TIM-3 says hello
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells
Wu Luo et al.
ONCOTARGET (2016)
An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells
Po-Chun Tseng et al.
ONCOTARGET (2016)
Galectin expression in cancer diagnosis and prognosis: A systematic review
Victor L. Thijssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
Koji Fujita et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest
Kiyoyuki Kobayashi et al.
ONCOLOGY REPORTS (2015)
Extracellular galectin-3 programs multidrug resistance through Na plus /K plus -ATPase and P-glycoprotein signaling
Yosuke Harazono et al.
ONCOTARGET (2015)
Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies
Shravan Madireddi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
Zhao-Yang Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
Filiberto Cedeno-Laurent et al.
BLOOD (2012)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
Valerie R. Wiersma et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity
Gisela M. Vaitaitis et al.
PLOS ONE (2012)
Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
Gaia Nebbia et al.
PLOS ONE (2012)
Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin
H. Sanchez-Ruderisch et al.
CELL DEATH AND DIFFERENTIATION (2011)
Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
Junya Kuroda et al.
MOLECULAR CANCER RESEARCH (2010)
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
T. Kobayashi et al.
LEUKEMIA (2010)
Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
Jihene Klibi et al.
BLOOD (2009)
Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface
Qicheng Zhao et al.
CANCER RESEARCH (2009)
Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
Huan-Yuan Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation
Gabriel A. Rabinovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis
Avraham Raz et al.
Anti-Cancer Agents in Medicinal Chemistry (2008)
Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices
Atsuya Nobumoto et al.
GLYCOBIOLOGY (2008)
Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells
S. H. Hsieh et al.
ONCOGENE (2008)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
The AP1-dependent secretion of galectin-1 by Reed - Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation
Ken S. Lau et al.
CELL (2007)
Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1-stimulated Jurkat T lymphocytes
Hermann Walzel et al.
GLYCOBIOLOGY (2006)
Clustering of pre-B cell integrins induces galectin-1-dependent pre-B cell receptor relocalization and activation
Benjamin Rossi et al.
JOURNAL OF IMMUNOLOGY (2006)
Dysregulated T cell expression of TIM3 in multiple sclerosis
Ken Koguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death
BN Stillman et al.
JOURNAL OF IMMUNOLOGY (2006)
Galectin-1: A link between tumor hypoxia and tumor immune privilege
QT Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Galectin-9 induces maturation of human monocyte-derived dendritic cells
SY Dai et al.
JOURNAL OF IMMUNOLOGY (2005)
Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer
A Irie et al.
CLINICAL CANCER RESEARCH (2005)
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege
N Rubinstein et al.
CANCER CELL (2004)
Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity
G Elad-Sfadia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional regulation
I Paron et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering
L Gauthier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance
T Kageshita et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation
A Paz et al.
ONCOGENE (2001)
Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation
M Demetriou et al.
NATURE (2001)
Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction
CD Chung et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
